Clinical Resources
Explore the most up-to-date clinical guidelines, tools, courses, and more.
Resources
By Disease
Find clinical resources and information for common movement disorders:
Clinical Tools
Evidence-Based Medicine Reviews
Review the latest recommendations from MDS's Evidence-Based Medicine Reviews, which use a rigorous methodological approach to outline treatment options.
Please wait while we gather your results.
Education
Courses for Clinicians
Browse live, in-person and on-demand courses tailored to clinicial care.
Please wait while we gather your results.
Advances in Technology and Artificial Intelligence Applications in Movement Disorders - VIRTUAL LIVE STREAM
Live Online
Dec 12, 2025 - Dec 13, 2025
Foundational / Beginner
1049 <p>MDS-ES Advances in Technology and Artificial Intelligence Applications in Movement Disorders delves into crucial aspects of the paradigm shift associated with AI and new technologies in clinical practice and their future challenges. This course will include different topics the application of AI and new technologies in clinical practice, research and teaching, engaging the audience in a comprehensive exploration of the multifaceted dimensions of these tools. Equally important aspects such as ethics and legal aspects of including AI and new technologies in clinical practice will also be covered. <strong><span style="background-color:#ccff00;">This registration site is for live stream registration only.</span></strong></p><p><strong><span style="background-color:#ccff00;"></span></strong><br /></p><p><strong>LIVE STREAM REGISTRATION DEADLINE</strong>: December 10, 2025<strong></strong></p> Anxiety/Depression, Ataxias, Autonomic Dysfunction, Botulinum toxin, Chorea/Huntingtons Disease (HD), Clinical Trials, Cognitive impairment/Dementia, Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Deep brain stimulation, Dopaminergic medications, Drug-induced Movement Disorders/Tardive dyskinesia, Dystonia, Freezing of Gait (FOG), Functional Movement Disorders, Gait & Balance Disorders, Genetic & Hereditary Disorders, Hyperkinetic Movement Disorders, Impulse Control Disorders, Infusion therapy, Lewy-body dementia (LBD), Medications for motor complications, Medications for motor symptoms, Medications for non-motor symptoms, Movement Disorders Emergencies, Multiple Systems Atrophy (MSA), Myoclonus, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Other Movement Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Psychosis, Rare/Uncommon Movement Disorders, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD), Sensory disorders, Sleep Disorders, Speech Disorders, Stiff Person syndrome (SPS), Therapies-Pharmacological, Therapies-Surgical, Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET) 720 0.00 https://education.movementdisorders.org/Detail/1049/MDS-ES-Advances-in-Technology-and-Artificial-Intelligence-Applications-in-Movement-Disorders---VIRTUAL-LIVE-STREAM https://education.movementdisorders.org/Upload/ActivityImages/25ESMD-Tech&AI_202x108552742.jpg 2025-12-12T00:00:00 2025-12-13T00:00:00 <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/25ESMD%20-%20Course%20Agenda%20Live%20Stream_31102025124928.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1738175528174_29012025123206.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/25ESMD%20-%20Course%20Agenda%20Live%20Stream_31102025124928.pdf" rel="noopener noreferrer" target="_blank">Course Schedule </a><strong> </strong><strong> </strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/3.%20Faculty%20Listing%20(w%20Photos)%20UPDATED_02092025051740.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/1738175528216_29012025123207.png" class="fr-fic fr-dii" style="width: 125px; height: 125px;"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/3.%20Faculty%20Listing%20(w%20Photos)%20UPDATED_02092025051740.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><em>Schedule as of October 31, 2025</em></p><p><br></p><p><strong>LIVE STREAM COURSE SCHEDULE</strong><br>All lectures, Q&A, and panel discussions will be streamed live from the in-person event on the dates/times listed below. Sessions will <u><strong>not</strong></u> be recorded for viewing on-demand. Registrants will receive a Zoom link to watch the live stream in their confirmation email and again closer to the course dates. If you do not receive a confirmation email, please contact <a data-fr-linked="true" href="mailto:education@movementdisorders.org">education@movementdisorders.org</a>.<br><br><strong><u>Day 1: Friday, December 12, 2025</u></strong><br><strong>Session 1: </strong>08:30 - 10:40 CET<br><em>Break: 10:40 - 11:10 CET</em><br><strong>Session 2:</strong> 11:10 - 12:40 CET</p><p><em>Break: 12:40 - 13:40 CET</em></p><p><strong>Session 3: </strong>13:40 - 17:10</p><p><em>Break: 15:10 - 15:40</em></p><p><br><strong><u>Day 2: Saturday, December 13, 2025</u></strong><br><strong>Session 4: </strong>11:35 - 13:00 CET</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Identify the current status and future landscapes of Artificial Intelligence and New Technologies<br>2. Relate the benefits and goals of application of Artificial Intelligence and New Technologies in patient-centered outcomes<br>3. Integration of Artificial Intelligence in the diagnosis, advanced therapies, HIFU and DBS teleprogramming in Parkinson´s disease.<br>4. Relate the ethics and legal aspects of integrating Artificial Intelligence and New Technologies in clinical practice</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, fellows, and transnational researchers and biomedical engineers.</p> <p align="center">MDS would like to thank the generous support of the following contributor in making the <em>MDS-ES Advances in Technology and Artificial Intelligence Applications in Movement Disorders – Live Stream</em> course possible.</p><p align="center"><br></p><p align="center"><strong><span style="font-size: 24px;">ESTEVE</span></strong></p> 0 /Courses/Advances-in-Technology-and-Artificial-Intelligence-Applications-in-Movement-Disorders---VIRTUAL-LIVE-STREAM.htm Advances in Technology and Artificial Intelligence Applications in Movement Disorders - VIRTUAL LIVE STREAM 2025-11-11T18:01:05.230 0 0 Foundational / Beginner Live Online Hyperkinetic Movement Disorders Non-motor Symptoms/Disorders Other Movement Disorders Parkinson Disease/Hypokinetic Movement Disorders Therapies-Pharmacological Therapies-Surgical
Diagnosis and Management of Motor Symptoms in Early Parkinson's Disease
On Demand
60 Minutes
Foundational / Beginner
CME Credits:1.00
1047 <p>This module will explore the clinical diagnostic criteria for Parkinson’s Disease (PD) with emphasis on early stage motor symptoms, as well as exploring atypical presentations and potential differentials. Treatment of early PD motor symptoms will be discussed using the evidence basis for approved therapies.</p> Biomarkers, Biomarkers & Diagnostic Tools, Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Etiology & Pathophysiology, Genetics, Lewy-body dementia (LBD), Medications for motor symptoms, Multiple Systems Atrophy (MSA), Neuroimaging, Neuropathology, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Rating Scales, Therapies-Pharmacological 60 1.00 https://education.movementdisorders.org/Detail/1047/Diagnosis-and-Management-of-Motor-Symptoms-in-Early-Parkinson's-Disease https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-44-001--Motor-Symptoms-in-Early-PD-202x108552477.jpg https://education.movementdisorders.org/Upload/BannerImages/05INTERACT-44-001--Motor-Symptoms-in-Early-PD-734x404583314.jpg 2025-11-06T00:00:00 2028-11-06T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Disclosures - Early PD_20102025113733.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>FACULTY</strong></p><p>Rob de Bie, MD, PhD - Amsterdam University Medical Center, Amsterdam, Netherlands</p><p>Monty Silverdale, MD, PhD - Manchester Centre for Clinical Neurosciences, Salford, United Kingdom</p><p>Ai Huey Tan, MD, PhD, FRCP - University of Malaya, Kuala Lumpur, Malaysia</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Obtain a good clinical history from a patient presenting with parkinsonian features.</p><p>2. Identify typical and atypical features in clinical examination of a patient presenting with parkinsonian features.</p><p>3. Develop a step-by-step approach in making a diagnosis of Parkinson’s disease based on the MDS Clinical Diagnostic Criteria.</p><p>4. Outline a treatment plan for managing motor symptoms in early Parkinson’s disease based on available clinical evidence.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Diagnosis-and-Management-of-Motor-Symptoms-in-Early-Parkinsons-Disease.htm Diagnosis and Management of Motor Symptoms in Early Parkinson's Disease 2025-11-06T15:01:05.570 0 0 Foundational / Beginner On-Demand Biomarkers & Diagnostic Tools Etiology & Pathophysiology Parkinson Disease/Hypokinetic Movement Disorders Therapies-Pharmacological
Journal CME 40.10: Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson’s Disease: A Longitudinal Multi-Cohort Study
On Demand
60 Minutes
Experienced / Intermediate
CME Credits:1.00
1046 <p>The Journal CME 40.10 article aims to evaluate the utility of polygenic scores (PGSs) for cognitive reserve proxies, including intelligence (INT), educational attainment (EA), and occupational attainment (OA), in predicting the clinical progression of PD.</p> Anxiety/Depression, Autonomic Dysfunction, Cognitive impairment/Dementia, Etiology & Pathophysiology, Genetics, Impulse Control Disorders, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Psychosis, Sensory disorders, Sleep Disorders, Speech Disorders Young Eun Huh, MD, PhD 60 1.00 https://education.movementdisorders.org/Detail/1046/Journal-CME-40-10:-Protective-Effects-of-Genetic-Proxies-of-Cognitive-Reserve-in-Parkinson’s-Disease:-A-Longitudinal-Multi-Cohort-Study https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-10-06T00:00:00 2026-10-06T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.10%20-%20Disclosures_01102025093927.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of cognitive reserve and its genetic proxies in influencing the progression of Parkinson’s disease</p><p>2. Assess the predictive value of polygenic scores for intelligence, educational attainment, and occupational attainment in clinical outcomes of PD</p><p>3. Evaluate how genetic markers of cognitive reserve can inform prognosis and contribute to personalized management strategies in PD</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-40.10-Protective-Effects-of-Genetic-Proxies-of-Cognitive-Reserve-in-Parkinsons-Disease-A-Longitudinal-Multi-Cohort-Study.htm Journal CME 40.10: Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson’s Disease: A Longitudinal Multi-Cohort Study Journal CME 40.10 2025-10-06T18:01:04.397 0 0 Experienced / Intermediate On-Demand Etiology & Pathophysiology Non-motor Symptoms/Disorders Parkinson Disease/Hypokinetic Movement Disorders
Journal CME 40.09: Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder
On Demand
60 Minutes
Foundational / Beginner
CME Credits:1.00
1044 <p>The Journal CME 40.09 article reports multicenter clinical (Expanded Disability Scoring Scale [EDSS]), neurocognitive), neuroimaging (Sundal score), and biological (neurofilament light chain [NfL]) outcomes after HSCT in CSF1R-RD.</p> Genetic & Hereditary Disorders, Infusion therapy, Other Movement Disorders, Therapies-Surgical Hemmo A.F. Yska, MD 60 1.00 https://education.movementdisorders.org/Detail/1044/Journal-CME-40-09:-Hematopoietic-Stem-Cell-Transplantation-in-an-International-Cohort-of-Colony-Stimulating-Factor-1-Receptor-(CSF1R)-Related-Disorder https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-09-24T00:00:00 2026-09-24T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.09%20-%20Disclosures_16092025021345.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the clinical rationale and early outcomes of HSCT in CSF1R-RD patients</p><p>2. Assess the significance of neuroimaging and biomarker changes post-HSCT</p><p>3. Evaluate the potential benefits and limitations of reduced-intensity conditioning in CSF1R-RD treatment</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-40.09-Hematopoietic-Stem-Cell-Transplantation-in-an-International-Cohort-of-Colony-Stimulating-Factor-1-Receptor-CSF1R-Related-Disorder.htm Journal CME 40.09: Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder Journal CME 40.09 2025-09-24T09:01:10.523 0 0 Foundational / Beginner On-Demand Other Movement Disorders Therapies-Surgical
Other Educational Resources
Please wait while we gather your results.
Get More Clinical Support
Join MDS
Members gain access to case videos, peer-to-peer collaboration opportunities, discounted education, and a variety of specialized programs.
Attend the International Congress
Discover the latest in the field, and connect with leaders from around the globe.